Subscribe to RSS
DOI: 10.1055/s-2004-815441
New Synthesis of Substituted Cyclopentanes via Reactions of γ-Chloro-carbanions with Electron-deficient Alkenes
Publication History
Publication Date:
29 January 2004 (online)
Abstract
Carbanions of 3-chloropropyl pentachlorophenylsulfone, although they undergo fast cyclization to the corresponding cyclopropyl sulfone, can be trapped with electrondeficient alkenes to produce carbanionic adducts that enter intramolecular substitution to form substituted cyclopentanes.
Key words
carbanions - cyclization - cyclopentane - Michael acceptors - sulfone
-
1a
Gronert S.Azizian K.Friedman MA. J. Am. Chem. Soc. 1998, 120: 3220 -
1b
Habusha U.Rozental E.Hoz S. J. Am. Chem. Soc. 2002, 124: 15006 -
2a
McCoy L. J. Am. Chem. Soc. 1960, 82: 6416 -
2b
Wendish D. In Houben-Weyl, Methoden der organischen Chemie Vol. IV 3: , Thieme; Stuttgart: 1971. p.89 -
2c
Fleming FF.Shook BC. Tetrahedron 2002, 58: 1 - 3
Zwanenburg B.De Kimpe N. In Houben-Weyl, Methoden der organischen Chemie Vol. E17a: Thieme; Stuttgart: 1997. p.45 - 4
Mann J. Comprehensive Organic Synthesis Vol. 3:Trost B. Pergamon; Oxford: 1991. p.839 -
5a
Paquette LA. Org. React. 1971, 25: 1 -
5b
Clough JM. Comprehensive Organic Synthesis Vol. 3:Trost B. Pergamon; Oxford: 1991. p.861 -
6a
M M.kosza Przyborowski J.Klajn R.Kwast A. Synlett 2000, 1773 -
6b
M M.kosza Judka M. Chem.-Eur. J. 2002, 8: 4234 -
7a
Collins SPW.Djuric W. Chem. Rev. 1993, 93: 1533 -
7b
Mathew J. Recent Progress in the Chemical Synthesis of Antibiotics, Lucas G. Vol. II: Springer Verlag; Heidelberg: 1993. p.435 -
7c
Mikol M.ajczyk Mikina M.Jankowska A. J. Org. Chem. 2000, 65: 5127 -
7d
Ghosh S.Patra D. Pure Appl. Chem. 1996, 68: 597 - 8
Hanselaer R.Samson M.Vandewalle M. Tetrahedron 1978, 34: 2393 -
9a
Hudlicky T.Price JD. Chem. Rev. 1989, 89: 1467 -
9b
Thebtaranonth C.Thebtaranonth Y. Tetrahedron 1990, 46: 1385 -
9c Survey of cyclopentane ring formation, see:
Larock RL. Comprehensive Organic Transformations 2nd ed.: Wiley-VCH; New York: 1999. p.168-174 -
9d
Du Y.Lu X.Zhang C. Angew. Chem. Int. Ed. 2003, 42: 1035 -
9e
Huart C.Ghosez L. Angew. Chem., Int. Ed. Engl. 1997, 36: 634 - 10
Silva LF. Tetrahedron 2002, 58: 9137
References
Typical Procedure. All reactions were performed in oven-dried glassware under argon. THF was freshly distilled from potassium-benzophenone. To a solution of 1 (117 mg, 0.3 mmol) in THF (5 mL) at -70 °C LDA (0.22 mL of 1.8 M solution, 0.4 mmol) was added in one portion. After 1-2 sec Michael acceptor dissolved in THF was added: 0.45 mmol in 0.5 mL of THF for the synthesis of 4, 7, 8, 9, 10; 0.6 mmol for 6, and 3 mmol for 5. The mixture was stirred for 5 min, warmed to r.t., quenched with aq NH4Cl, extracted and purified by column and preparative TLC chromatography (hexane/EtOAc as eluent).
Compound 1: mp 124 °C; 1H NMR (200 MHz, CDCl3): δ = 2.31-2.46 (m, 2 H), 3.67-3.78 (m, 4 H). 13C NMR (50 MHz, CDCl3): δ = 25.93, 43.12, 53.77, 134.51, 135.67, 135.97, 139.83.
Compound 2: mp 169 °C; 1H NMR (400 MHz, CDCl3): δ = 1.12-1.16 (m, 2 H), 1.50-1.55 (m, 2 H), 3.20 [tt, 3
J(H,H) = 4.77, 7.88 Hz, 1 H]. 13C NMR (100 MHz, CDCl3): δ = 6.06, 32.69, 133.20, 134.87, 137.45, 138.47.
Compound 3: cis-isomer, mp 125 °C; 1H NMR (400 MHz, CDCl3): δ = 1.42 (s, 9 H), 2.13-2.26 (m, 3 H), 2.90-3.08 (m, 2 H), 4.59 [dd, 3
J(H,H) = 6.97, 7.43 Hz, 1 H], 4.75-4.80 (m, 1 H). 13C NMR (100 MHz, CDCl3): δ = 26.53, 27.81, 28.28, 48.83, 66.23, 75.09, 82.76, 132.48, 133.21, 136.81, 168.86.
Compound 3: trans-isomer, mp 120 °C. 1H NMR (400 MHz, CDCl3): δ = 1.42 (s, 9 H), 2.20-2.31 (m, 1 H), 2.33-2.41 (m, 2 H), 2.76-2.83 (m, 1 H), 3.12-3.21 (m, 1 H), 4.27-4.34 (m, 1 H), 4.62 [t, 3
J(H,H) = 6.87 Hz, 1 H], 4.73 [dt, 3
J(H,H) = 2.20, 8.72 Hz, 1 H]. 13C NMR (100 MHz, CDCl3): δ = 26.64, 27.82, 28.59, 49.27, 67.58, 74.68, 82.78, 132.77, 133.28, 136.65, 169.19. Anal. calcd (%) for C16H17Cl5O4S (482.63): C, 39.82; H, 3.55; Cl, 36.73; S, 6.64. Found: C, 39.93; H, 3.63; Cl, 36.82; S, 6.60.
Compound 4: cis-isomer, mp 156 °C; 1H NMR (200 MHz, CDCl3): δ = 2.21-2.33 (m, 2 H), 2.78-2.83 (m, 2 H), 3.31 [t, 3
J(H,H) = 10.01 Hz, 1 H], 4.26-4.44 (m, 1 H), 4.72-4.82 (m, 1 H), 5.57-5.65 (m, 1 H), 7.56-7.94 (m, 5 H). 13C NMR (100 MHz, CDCl3): δ = 25.02, 28.28, 65.95, 67.85, 75.30, 128.23, 129.35, 129.50,134.17, 134.52, 135.43, 135.84, 139.21.
Compound 4: trans-isomer, oil. 1H NMR (200 MHz, CDCl3): δ = 2.17-2.33 (m, 2 H), 2.89 [dt, 3
J(H,H) = 6.60, 14.43 Hz, 1 H], 3.03-3.20 (m, 2 H), 4.26-4.41 (m, 1 H), 4.72-4.84 (m, 1 H), 5.47-5.54 (m, 1 H), 7.54-7.93 (m, 5 H). 13C NMR (100 MHz, CDCl3): δ = 25.57, 27.74, 66.91, 68.88, 75.46, 128.42, 129.46, 129,82, 132.96, 133.98, 134.57, 135.18, 138.78.
Comound 5: cis-isomer, mp 197 °C; 1H NMR (400 MHz, CDCl3): δ = 1.98 (s, 3 H), 2.17-2.38 (m, 2 H), 2.64 [dd, 3
J(H,H) = 2.39, 15.96 Hz, 1 H], 2.94 [dd, 3
J(H,H) = 9.36, 15.96 Hz, 1 H], 3.17-3.25 (m, 1 H), 3.73 (s, 3 H), 4.64 [dt, 3
J(H,H) = 2.38, 8.62 Hz, 1 H]. 13C NMR (100 MHz, CDCl3): δ = 26.91, 29.61, 34.58, 53.11, 54.36, 64.93, 73.21 133.67, 133.75, 138.16, 175.53.
Compound 5: trans-isomer, mp 148 °C; 1H NMR (400 MHz, CDCl3): δ = 2.01 (s, 3 H), 2.15-2.22 (m, 2 H), 2.60 [dd, 3
J(H,H) = 4.22, 15.77 Hz, 1 H], 2.92 [dd, 3
J(H,H) = 7.7, 15.59 Hz, 1 H], 3.09-3.16 (m, 1 H), 3.73 (s, 3 H), 4.19-4.25 (m, 1 H), 4.64-4.69 (m, 1 H). 13C NMR (100 MHz, CDCl3): δ = 28.01, 29.54, 34.22, 53.03, 54.36, 64.72, 73.94, 133.65, 133.77, 138.16, 138.58, 175.65.
Compound 6: mp 167 °C; 1H NMR (200 MHz, CDCl3): δ = 1.18 [t, 3
J(H,H) = 7.16 Hz, 3 H], 2.00-2.14 (m, 1 H), 2.38-2.60 (m, 1 H), 3.60 [dd, 3
J(H,H) = 6.00, 11.68 Hz, 1 H], 4.14 [dq, 3
J(H,H) = 2.56, 7.14 Hz, 2 H], 4.25-4.57 (m, 2 H), 4.87-4.96 (m, 2 H), 7.20-7.37 (m, 5 H). 13C NMR (50 MHz, CDCl3): δ = 13.89, 26.05, 44.83, 53.03, 61.62, 72.27, 128.19, 128.98, 130.38, 133.48, 134.47, 135.41, 137.77, 169.33.
Compound 7: mp 232 °C; 1H NMR (400 MHz, CDCl3): δ = 1.90-2.07 (m, 1 H), 2.44-2.55 (m, 1 H), 3.65-3.74 (m, 1 H), 4.41-4.47 (m, 2 H), 4.86 [t, 3
J(H,H) = 7.89 Hz, 1 H], 5.46 [d, 3
J(H,H) = 5.32 Hz, 1 H], 7.23-7.61 (m, 10 H). 13C NMR (100 MHz, CDCl3): δ = 26.09, 45.26, 56.95, 71.99, 76.27, 127.55, 128.16, 128.27, 128.69, 132.58, 133.25, 133.78, 134.70, 136.20, 136.79, 196.14.
Compound 9: trans-isomer, mp 234 °C; 1H NMR (400 MHz, CDCl3): δ = 2.67-2.88 (m, 3 H), 2.92-2.98 (m, 1 H) 4.72 [d, 3
J(H,H) = 9.72 Hz, 1 H], 4.76-4.86 (m, 1 H), 7.23-7.28 (m, 3 H), 7.33-7.38 (m, 1 H). 13C NMR (50 MHz, CDCl3): δ = 23.62, 38.26, 42.20, 50.90, 64.25, 112.81, 113.18, 127.28, 128.11, 128.59, 130.03.61, 130.61, 132.91, 133.76, 135.06, 135.12, 139.48.
Compound 10: trans-isomer, mp 216 °C; 1H NMR (500 MHz, CDCl3): δ = 1.92 [dddd, 3
J(H,H) = 3.40, 6.80, 9.15 Hz, 2
J(H,H) = 15.50 Hz, 1 H], 2.60 [dddd, 3
J(H,H) = 4.95, 5.80, 8.80 Hz, 2
J(H,H) = 15.50 Hz, 1 H], 3.61 [ddd, 3
J(H,H) = 6.80, 4.95 Hz, 2
J(H,H) = 11.50 Hz, 1 H], 3.82 [ddd, 3
J(H,H) = 5.85, 9.10 Hz, 2
J(H,H) = 11.50 Hz, 1 H], 4.26 [ddd, 3
J(H,H) = 12.00, 8.80, 3.40 Hz, 1 H], 4.42 [d, 3
J(H,H) = 12.00 Hz, 1 H], 6.57 [dd, 3
J(H,H) = 1.90, 3.40 Hz, 1 H], 6.83 [d, 3
J(H,H) = 3.35 Hz, 1 H], 7.65 [d, 3
J(H,H) = 1.55 Hz, 1 H]. 13C NMR (100 MHz, CDCl3): δ = 28.21, 40.87, 42.65, 45.02, 56.77, 110.04, 111.03, 111.56, 114.71, 123.84, 132.18, 133.96, 136.57, 139.98, 140.18, 143.53, 145.29.
Compound 10: cis-isomer, mp 158 °C; 1H NMR (400 MHz, CDCl3): δ = 2.60-2.89 (m, 4 H), 4.17 [d, 3
J(H,H) = 10.08 Hz, 1 H], 4.87-4.95 (m, 1 H), 6.19 [dd, 3
J(H,H) = 1.47, 3.30 Hz, 1 H], 6.29 [d, 3
J(H,H) = 3.29 Hz, 1 H], 7.24 [d, 3
J(H,H) = 1.28 Hz, 1 H]. 13C NMR (100 MHz, CDCl3): δ = 23.03, 37.23, 41.77, 50.53, 62.59, 110.68, 110.86, 112.73, 113.34, 133.55, 133.78, 135.04, 139.56, 144.15, 144.28.